Many infants recovering from acute lung disease and pulmonary hypertension still have evidence of reactive airways disease at one year of age, suggesting longer-term airway effects. We hypothesized that parallel changes in smooth muscle would occur in airways and pulmonary arteries from animals with pulmonary hypertension and during normoxic recovery. Thus, two-hour-old piglets were subjected to 3 d chronic hypobaric hypoxia and 3-d-old piglets were subjected to 11 d hypoxia. Some animals were allowed to recover in room air for 3 or 6 d. The amount of smooth muscle and responses of isolated paired bronchial and pulmonary artery rings to endothelin-1 (ET-1) and norepinephrine were studied at the end of hypoxic exposure, on recovery and in age-matched control animals. In all hypoxia induced pulmonary hypertensive animals, smooth muscle area and ET-1 contractile response was increased in the pulmonary arteries and bronchi. Norepinephrine-induced relaxant response was impaired significantly in both bronchi and pulmonary arteries. After 3 d recovery, pulmonary arterial smooth muscle area decreased by 65%, and ET-1-induced contractile responses were normal for age. In the airways, ET-1 contractile response only normalized after six days and bronchial smooth muscle was still increased. After 6 d recovery pulmonary arterial norepinephrineinduced relaxant response had returned to normal, but bronchial response remained impaired. Thus during pulmonary hypertension, both bronchial and pulmonary arterial smooth muscle area and contractile responses are increased. On recovery, regression of bronchial structural and functional abnormalities is slower than in pulmonary arteries. A natomically, the pulmonary arteries and airways lie in close proximity and local mediator release may affect both bronchial and pulmonary vascular reactivity. Pulmonary hypertension in children with congenital heart disease is associated not only with an elevated pulmonary arterial vascular resistance and medial smooth muscle hypertrophy, but also with increased respiratory system resistance and bronchial smooth muscle hypertrophy (1).Fifty percent of infants requiring Extra Corporeal Membrane Oxygenation (ECMO) for persistent pulmonary hypertension of the newborn still required pulmonary medications after six months, despite ECMO utilizing a strategy of lung rest to prevent lung injury (2). Twenty-six percent of infants who participated in the UK randomized ECMO trial, many of whom had severe persistent pulmonary hypertension, still had evidence of reactive airways disease with cough and wheeze at one year of age, and 8% still required regular pulmonary medications (3). These changes could be due to the damaging effects of high pressure and the high FiO 2 used during the mechanical ventilation given before instituting ECMO (4), however pulmonary hypertension may have contributed to the end result by affecting both the pulmonary arteries and bronchi. The clinical findings also suggest that any bronchial changes, once present, are slow to re...